Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers
Home › MA › WESTFIELD › BAYSTATE NOBLE HOSPITAL CORPORATION

BAYSTATE NOBLE HOSPITAL CORPORATION

NPI: 1700816048 · WESTFIELD, MA 01085 · General Acute Care Hospital · NPI assigned 07/03/2006

$21.93M
Total Medicaid Paid
559,872
Total Claims
484,408
Beneficiaries
177
Codes Billed
2018-01
First Month
2024-12
Last Month

Provider Details

Authorized OfficialWITHERELL, DAVID (SENIOR DIRECTOR, PAYMENT SYSTEMS)
NPI Enumeration Date07/03/2006

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 78,707 $3.97M
2019 78,491 $2.34M
2020 65,947 $1.84M
2021 86,214 $2.82M
2022 97,920 $3.84M
2023 89,636 $4.06M
2024 62,957 $3.07M

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
99283 Emergency department visit for the evaluation and management, moderate severity 29,267 27,070 $4.03M
99284 Emergency department visit for the evaluation and management, high severity 26,697 24,256 $3.72M
99285 Emergency department visit for the evaluation and management, high severity with immediate threat to life 13,973 12,567 $2.21M
96361 Intravenous infusion, hydration; each additional hour 7,091 6,002 $2.17M
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 15,868 4,582 $863K
99282 Emergency department visit for the evaluation and management, low to moderate severity 6,155 5,854 $783K
74177 Computed tomography, abdomen and pelvis; with contrast material 5,764 5,493 $755K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple 940 908 $733K
70450 Computed tomography, head or brain; without contrast material 5,225 4,903 $644K
S9485 Crisis intervention mental health services, per diem 1,105 776 $537K
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel 7,177 6,448 $433K
74176 Computed tomography, abdomen and pelvis; without contrast material 2,034 1,969 $429K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 3,569 3,002 $309K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour 1,992 1,901 $237K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 6,364 5,600 $197K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 36,096 30,887 $161K
93971 1,092 1,034 $157K
76705 Ultrasound, abdominal, real time with image documentation; limited 1,872 1,793 $155K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 4,088 3,799 $145K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 2,458 2,236 $140K
97161 2,560 2,410 $139K
77063 Screening digital breast tomosynthesis, bilateral 2,410 2,365 $133K
71046 Radiologic examination, chest; 2 views 14,298 13,227 $133K
G2023 Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source 7,103 6,417 $131K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction 1,967 1,766 $130K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete 744 733 $114K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete 818 798 $112K
77067 Screening mammography, bilateral, including computer-aided detection 3,033 2,981 $101K
87631 1,431 1,376 $101K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) 3,973 1,317 $100K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 14,519 13,049 $82K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour 425 361 $80K
76830 Ultrasound, transvaginal 774 764 $78K
84484 10,982 9,274 $71K
45385 Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) 72 71 $68K
M0243 Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring 243 233 $67K
G0378 Hospital observation service, per hour 1,861 1,688 $66K
76700 Ultrasound, abdominal, real time with image documentation; complete 309 298 $59K
83605 8,575 7,607 $58K
45380 Colonoscopy, flexible; with biopsy, single or multiple 81 81 $52K
83880 2,829 2,595 $51K
J0248 Injection, remdesivir, 1 mg 142 51 $48K
80048 Basic metabolic panel (calcium, ionized) 14,603 12,398 $47K
83690 11,017 9,914 $47K
Q0222 Injection, bebtelovimab, 175 mg 96 80 $47K
80053 Comprehensive metabolic panel 8,606 7,780 $42K
93975 415 409 $42K
71275 Computed tomographic angiography, chest, with contrast material 383 360 $42K
81025 7,387 6,894 $40K
M0247 Intravenous infusion, sotrovimab, includes infusion and post administration monitoring 162 147 $38K
76770 283 274 $34K
87086 Culture, bacterial; quantitative colony count, urine 6,341 5,887 $31K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A 2,537 2,433 $27K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 908 810 $25K
84443 Thyroid stimulating hormone (TSH) 2,640 2,514 $25K
97014 937 312 $24K
72100 1,167 1,115 $23K
80051 13,094 11,420 $23K
87088 2,992 2,170 $23K
73030 1,303 1,263 $23K
73630 1,544 1,487 $21K
85379 3,405 3,176 $21K
81001 10,442 9,644 $20K
73562 544 501 $19K
73560 1,311 1,270 $19K
87040 2,922 1,695 $18K
96375 Therapeutic injection; each additional sequential IV push 10,850 9,315 $18K
73610 1,507 1,427 $18K
ATP14 1,970 1,573 $17K
G0121 Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk 13 13 $16K
83735 4,345 3,747 $16K
99291 Critical care, evaluation and management of the critically ill patient, first 30-74 minutes 94 91 $16K
ATP08 2,386 1,877 $15K
71045 Radiologic examination, chest; single view 3,778 3,495 $14K
84703 2,492 2,365 $14K
82947 12,301 11,021 $13K
85610 6,828 5,570 $12K
82565 12,836 11,288 $12K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 18,883 16,613 $12K
87081 1,981 1,903 $11K
ATP07 1,587 1,274 $11K
84520 12,775 11,266 $10K
70496 64 62 $9K
73130 699 670 $9K
M0222 Intravenous injection, bebtelovimab, includes injection and post administration monitoring 92 89 $9K
86140 2,411 2,152 $8K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 5,565 4,436 $7K
80076 2,654 2,324 $7K
71260 Computed tomography, thorax, diagnostic; with contrast material 125 124 $7K
70551 Magnetic resonance imaging, brain; without contrast material 60 57 $6K
81000 3,126 2,845 $6K
73110 396 375 $6K
ATP11 838 673 $6K
81003 4,231 3,984 $6K
88305 Level IV - Surgical pathology, gross and microscopic examination 2,961 2,731 $5K
90715 235 233 $5K
72125 Computed tomography, cervical spine; without contrast material 770 724 $5K
G0463 Hospital outpatient clinic visit for assessment and management of a patient 159 126 $5K
M0239 Intravenous infusion, bamlanivimab-xxxx, includes infusion and post administration monitoring 29 28 $5K
84450 5,496 5,044 $5K
94060 71 66 $5K
84460 5,409 4,967 $5K
84075 5,085 4,676 $4K
82247 5,053 4,653 $4K
76642 53 50 $4K
71250 56 56 $4K
ATP15 502 423 $4K
76536 39 39 $4K
87186 724 682 $4K
85027 951 778 $4K
J2405 Injection, ondansetron hydrochloride, per 1 mg 9,499 8,101 $4K
J1885 Injection, ketorolac tromethamine, per 15 mg 7,677 6,986 $3K
96376 3,858 2,608 $3K
87070 351 331 $2K
12001 12 12 $2K
94729 70 65 $2K
73502 136 129 $2K
J1170 Injection, hydromorphone, up to 4 mg 2,428 1,637 $2K
94726 57 53 $2K
82962 4,310 2,849 $1K
87147 331 315 $1K
J3490 Unclassified drugs 946 731 $1K
J2704 Injection, propofol, 10 mg 5,064 4,748 $1K
70491 13 12 $1K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine 448 402 $1K
81002 782 728 $1K
84100 963 798 $1K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe 38 38 $1K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe 39 39 $1K
J1100 Injection, dexamethasone sodium phosphate, 1 mg 1,105 1,046 $1K
J3010 Injection, fentanyl citrate, 0.1 mg 995 897 $1K
85730 352 336 $1K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml 5,859 5,095 $966.90
G0283 Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care 161 41 $720.94
J1200 Injection, diphenhydramine hcl, up to 50 mg 368 325 $712.95
36415 Collection of venous blood by venipuncture 6,831 5,923 $633.09
J2270 Injection, morphine sulfate, up to 10 mg 2,952 2,313 $555.44
87103 92 84 $508.73
J0696 Injection, ceftriaxone sodium, per 250 mg 1,461 1,190 $500.74
J1650 Injection, enoxaparin sodium, 10 mg 106 58 $452.25
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism 14 13 $395.96
87476 14 13 $393.04
73140 47 45 $334.28
C9803 Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source 2,637 2,413 $213.92
84702 13 12 $172.51
86618 12 12 $165.22
J2272 Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg 294 222 $150.21
J0690 Injection, cefazolin sodium, 500 mg 43 41 $141.47
J2250 Injection, midazolam hydrochloride, per 1 mg 162 162 $141.47
73590 12 12 $132.74
87077 30 29 $126.68
ATP09 23 16 $125.44
82550 70 63 $112.77
82010 15 14 $82.06
96367 17 16 $56.57
J2060 Injection, lorazepam, 2 mg 986 860 $54.92
86308 12 12 $54.84
73080 15 13 $50.65
J2765 Injection, metoclopramide hcl, up to 10 mg 622 568 $44.39
J1630 Injection, haloperidol, up to 5 mg 161 148 $1.25
Q0247 Injection, sotrovimab, 500 mg 81 67 $0.08
A9575 Injection, gadoterate meglumine, 0.1 ml 341 288 $0.00
G8979 Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting 51 50 $0.00
80061 Lipid panel 27 26 $0.00
Q0244 Injection, casirivimab and imdevimab, 1200 mg 49 48 $0.00
G8978 Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals 51 50 $0.00
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg 15 13 $0.00
94664 27 27 $0.00
J0780 Injection, prochlorperazine, up to 10 mg 14 12 $0.00
Q0245 Injection, bamlanivimab and etesevimab, 2100 mg 13 12 $0.00
J3475 Injection, magnesium sulfate, per 500 mg 12 12 $0.00
94760 574 328 $0.00
36416 553 439 $0.00
G8980 Mobility: walking & moving around functional limitation, discharge status, at discharge from therapy or to end reporting 15 14 $0.00
70498 24 24 $0.00
G0008 Administration of influenza virus vaccine 12 12 $0.00
C9285 Lidocaine 70 mg/tetracaine 70 mg, per patch 15 12 $0.00